Connection between inflammatory markers, antidepressants and depression

Acta Clinica Croatica

Volumn 51, Issue 1, 2012, Pages 25-33

  Crnković, Danijel ^a   Buljan, Danijel ^a   Karlović, Dalibor ^a   Krmek, Marija ^b  

^a University Department of Psychiatry   (Croatia)

^b Center for Child Protection   (Croatia)

Author keywords

Cytokines; Depression; Mechanism of antidepressant action

Indexed keywords

ANTIDEPRESSANT AGENT; C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFICACY; FEMALE; HAMILTON ANXIETY SCALE; HUMAN; INFLAMMATION; MAJOR DEPRESSION; MALE; BLOOD;

ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84868654265     PISSN: 03539466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. th ed. Baltimore, MD, USA: Williams & Wilkins, 1995.
2. Kemperman G, Kronenberg G. Depressed new neurons? Adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol Psychiatry 2003;54:499-503.
3. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000;157:683-94.
4. Leonard BE. The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:767-80.
5. Raison CL, Miller AH. The neuroimmunology of stress and depression. Semin Clin Neuropsychiatry 2001;6:277-94.
6. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 2007;21:374-83.
7. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Rev Neurosci 2008;9:46-56.
8. Mesquita AR, Correia-Neves M, Roque S, et al. IL -10 modulates depressive-like behavior. J Psychiatr Res 2008;43:89-97.
9. Yong-Ku K, Kyeong-Sae N, Kyung-Ho S, Han Yong J, So-Hyun C, Jung-Bum K. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1044-53.
10. Schiepers O, Wichers M, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:201-17.
11. Maes M. Major depression and activation of the inflammatory response system. Adv Exp Med Biol 1999;461:25-46.
12. Maes M, Scharpe S, Meltzer HY. Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression. Biol Psychiatry 1993;34:690-701.
13. Maes M, Capuron L, Ravaud A. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy. Neuropsychopharmacology 2001;24:130-40.
14. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:11-38.
15. Berk M, Wadee AA, Kuschke RH, O'Neill-Kerr A. Acute phase proteins in major depression. J Psychosom Res 1997;43:529-34.
16. Maes M, Bosmans E, Meltzer HY. Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry 1993;150:1189-93.
17. Levine J, Barak Y, Chengappa KN. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 1999;40:171-6.
18. Fornaro M, Martino M, Battaglia F, Colicchio S, Perugi G. Increase in IL -6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation. Neuropsychiatr Dis Treat 2011;7:51-6.
19. Tulner DM, Smith OR, Schins A, de Jonge P, Quere M, Delanghe JR, Crijns HJ, den Boer JA, Korf J, Honig A. Antidepressive effect of mirtazapine in post-myocardial infarction depression is associated with soluble TNF -R1 increase: data from the MIND -IT. Neuropsychobiology 2011;63:169-76.
20. Dinan TG. Inflammatory markers in depression. Curr Opin Psychiatry 2009;22:32-6.
21. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000;22:4.
22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders DSM-IV-TR (Text Revision), 2000.
23. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):34-57.
24. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
25. Yoshimura R, Hikaru H, Atsuko I-S, Wakako U-N, Nobuhisa U, Jun N. Higher plasma interleukin-6 (IL -6) level is associated with SSRI - or SNRI -refractory depression. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:722-6.
26. Wrona D. Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. J Neuroimmunol 2006;172:38-58.
27. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31.
28. Dantzer R, Wollman E, Vitkovic L, Yirimya R. Cytokines and depression: fortuitous or causative association. Mol Psychiatry 1994;4:328-32.
29. Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, Kirchner H. Inflammatory markers in major depression and melancholia. J Affect Disord 2001;63:93-102.
30. Danner M, Kasl SV, Abramson JL, Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom Med 2003;65:347-56.
31. Watkins MSF. Cytokines for psychologists: implications of bidirectional immune to brain communication for understanding behavior, mood and cognition. Psychol Rev 1998;105:83-107.
32. Maes M. Depression is an inflammatory disease, but cellmediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 2010, doi:10.1016/j.pnpbp.2010.06.014.
33. O'Brien SM, Scott LV, Dinan TG. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol Clin Exp 2004;19:397-403.
34. Kubera M, Kenis G, Bosmans E, Kajta M, Basta-Kaim A, Scharpe S, Budziszewska B, Maes M. Stimulatory effect of antidepressants on the production of IL -6. Int Immunopharmacol 2004;4:185-92.
35. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology 2003;170:429-33.
36. Smith RS. The macrophage theory of depression. Med Hypotheses 2001;35:298-306.